MAGN:NYSEMagnera Corporation Analysis
Data as of 2026-06-18 - not real-time
$12.03
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Magnera’s stock is trading close to its technical support level, with the short‑term moving average just edging above the longer‑term average, suggesting a subtle bullish bias. The RSI sits in the upper‑mid range, indicating momentum is still intact, while the MACD histogram remains positive, reinforcing the bullish signal. However, the 30‑day volatility is elevated and the beta is well above one, flagging heightened price swings relative to the market. Fundamentals show declining revenue, thin gross margins and a negative trailing EPS, underscoring ongoing profitability challenges. Yet the discounted cash flow model projects a fair value substantially higher than the current price, implying a notable upside potential.
The recent launch of the Universa line of industrial wipers adds a fresh growth catalyst that could improve top‑line momentum, but the company remains unprofitable and carries a high debt load, limiting financial flexibility. With no dividend and a low price‑to‑book ratio, the stock appears attractively priced from a value standpoint, though investors must weigh the operational turnaround risk. Overall, the blend of technical support, undervalued valuation, and product‑line expansion creates a cautiously optimistic outlook tempered by earnings volatility and sector‑specific regulatory exposure.
The recent launch of the Universa line of industrial wipers adds a fresh growth catalyst that could improve top‑line momentum, but the company remains unprofitable and carries a high debt load, limiting financial flexibility. With no dividend and a low price‑to‑book ratio, the stock appears attractively priced from a value standpoint, though investors must weigh the operational turnaround risk. Overall, the blend of technical support, undervalued valuation, and product‑line expansion creates a cautiously optimistic outlook tempered by earnings volatility and sector‑specific regulatory exposure.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Technical support near current price
- Bullish MACD but high short‑term volatility
- Negative earnings and thin margins
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued relative to DCF fair value
- Potential revenue boost from new Universa product line
- Improving cash flow generation
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant upside potential if turnaround succeeds
- Low price‑to‑book and price‑to‑sales multiples
- Defensive consumer sector cushioning against cycles
Key Metrics & Analysis
Financial Health
Revenue Growth-3.40%
Profit Margin-3.37%
P/E Ratio7.1
ROE-10.32%
ROA1.98%
Debt/Equity188.55
P/B Ratio0.4
Op. Cash Flow$185.0M
Free Cash Flow$201.0M
Technical Analysis
TrendNeutral
RSI58.7
Support$10.16
Resistance$13.00
MA 20$11.58
MA 50$10.95
MA 200$11.71
MACDBullish
VolumeStable
Fear & Greed Index91.18
Valuation
Fair Value$28.42
Target Price$14.50
Upside/Downside20.53%
GradeUndervalued
TypeValue
Risk Assessment
Beta1.45
Volatility47.15%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.